Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 8/2015

01-08-2015 | Letter to the Editor

Trastuzumab in metastatic breast cancer after complete remission: How long is enough?

Authors: Arzu Oguz, Samed Rahatli, Ozden Altundag, Kadri Altundag

Published in: Medical Oncology | Issue 8/2015

Login to get access

Excerpt

To the Editor, …
Literature
1.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, et al. Pertuzumab, Trastuzumab and Docetaxel in HER2 positive metastatic breast cancer. NEJM. 2015;372:724–34.PubMedCrossRef
2.
Arciénega II, Imesch P, Fink D, Dedes KJ. Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: A case report and review of the literature. Target Oncol. 2015;10(2):297–301.CrossRef
3.
Yan M, Lv HM, Zhang MW, Cui SD. Maintenance treatment of trastuzumab for patients with advanced breast cancer to achieve long term survival: Two case reports and literature review. Chin J Cancer Res. 2014;26(4):486–92.PubMedCentralPubMed
4.
Montemurro F, Prat A, Rossi V, Valabrega G, Sperinde J, Peraldo-Neia C, et al. Potential biomarkers of long term benefit from single agent trastuzumab or lapatinib in HER 2 positive metastatic breast cancer. Mol Oncol. 2014;8(1):20–6.PubMedCrossRef
Metadata
Title
Trastuzumab in metastatic breast cancer after complete remission: How long is enough?
Authors
Arzu Oguz
Samed Rahatli
Ozden Altundag
Kadri Altundag
Publication date
01-08-2015
Publisher
Springer US
Published in
Medical Oncology / Issue 8/2015
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-015-0648-1

Other articles of this Issue 8/2015

Medical Oncology 8/2015 Go to the issue

Original Paper

FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis

Letter to the Editor

The effect of young age on survival in breast cancer: early results

Original Paper

Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib

Original Paper

Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer

Original Paper

The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation

Original Paper

A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits